Peripheral artery disease in pseudoxanthoma elasticum: Walking capacity on the 6-minute walking test - Report - MDSpire

Peripheral artery disease in pseudoxanthoma elasticum: Walking capacity on the 6-minute walking test

  • By

  • Melanie Haverkamp

  • Frank LJ Visseren

  • Constantijn EVB Hazenberg

  • Pim A de Jong

  • Wilko Spiering

  • June 11, 2026

  • 0 min

Share

Clinical Report: Walking Ability Assessment in Peripheral Artery Disease Associated with Pseudoxanthoma Elasticum

Overview

This study evaluates walking distances in patients with Pseudoxanthoma elasticum (PXE) and peripheral artery disease (PAD) using the 6-minute walk test (6MWT). Results indicate significantly reduced walking capacity in PXE patients compared to healthy references, particularly in younger individuals.

Background

Pseudoxanthoma elasticum (PXE) is a genetic disorder linked to ectopic calcifications, leading to complications such as peripheral artery disease (PAD). PAD is notably more prevalent in PXE patients than in the general population, affecting their quality of life through symptoms like claudication. Understanding walking ability in this population is crucial for managing their health outcomes.

Data Highlights

GroupMean Walking Distance (m)Difference from Reference (m)
Women with PXE533 ± 96–32 (95% CI: −50 to −13)
Men with PXE–69 (95% CI: −93 to −44)
Patients < 50 yearsWomen: −66 (95% CI: −89 to −42)
Men: −102 (95% CI: −148 to −69)
Patients with PAD496 ± 109–60 (95% CI: −89 to −32)
Patients without PAD554 ± 79–53 (95% CI: −87 to −19)

Key Findings

  • PAD affects over 50% of patients with PXE, occurring at younger ages than in the general population.
  • The mean walking distance in women with PXE was significantly lower than reference values.
  • Among younger patients (< 50 years), walking distances were significantly reduced compared to healthy references.
  • 69% of patients with PXE had lower walking distances compared to their healthy counterparts.
  • Patients with PAD had a mean walking distance of 496 ± 109 meters, significantly below reference values.

Clinical Implications

The findings highlight the need for regular assessment of walking ability in PXE patients, particularly those with PAD. Clinicians should consider the impact of early-onset vascular involvement on functional capacity when managing these patients.

Conclusion

Walking capacity in patients with PXE is significantly reduced, emphasizing the importance of monitoring and addressing functional limitations in this population.

Related Resources & Content

  1. JAMA Ophthalmology, 2023 -- Pseudoxanthoma Elasticum and the Logic of its Ocular Manifestations
  2. Society for Vascular Surgery Clinical Practice Guideline on the management of intermittent claudication: Focused update - PubMed
  3. New England Journal of Medicine, 2025 -- Peripheral Artery Disease in the Legs
  4. Clinical Research in Cardiology — Automated Oscillometric Measurement of Blood Pressure and Pulse Waveforms for Assessing Vascular Stiffness in Atherosclerotic Conditions
  5. Clinical Rheumatology — Association of Exercise Self-Efficacy and Patient Global Assessment with 6-Minute Walk Test Performance in Individuals with Rheumatoid Arthritis
  6. Clinical Rheumatology — Assessment of the Londrina Activities of Daily Living Protocol's Reliability and Validity in Patients with Systemic Sclerosis
  7. Pediatric Cardiology — Assessment of Pediatric Pulmonary Arterial Hypertension Using the Six-Minute Walk Test
  8. Pseudoxanthoma Elasticum and the Logic of its Ocular Manifestations | Dermatology | JAMA Ophthalmology | JAMA Network
  9. Society for Vascular Surgery Clinical Practice Guideline on the management of intermittent claudication: Focused update - PubMed
  10. Peripheral Artery Disease in the Legs | New England Journal of Medicine

Original Source(s)

Related Content